DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Nitroglycerin is a drug marketed by Hercon Pharm, Lannett Co Inc, Mylan Technologies, Abraxis Pharm, Am Regent, Hospira, Intl Medication, Luitpold, Smith And Nephew, Fougera Pharms Inc, Perrigo Israel, Actavis Labs Fl Inc, Alvogen, Dr Reddys, Glenmark Pharms Sa, Rubicon, Sigmapharm Labs Llc, and Baxter Hlthcare. and is included in twenty-seven NDAs.
The generic ingredient in NITROGLYCERIN is nitroglycerin. There are thirty-six drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the nitroglycerin profile page.
A generic version of NITROGLYCERIN was approved as nitroglycerin by AM REGENT on May 24th, 1988.
Summary for NITROGLYCERIN
|Finished Product Suppliers / Packagers:||16|
|Raw Ingredient (Bulk) Api Vendors:||34|
|Formulation / Manufacturing:||see details|
|Drug Prices:||Drug price information for NITROGLYCERIN|
|Drug Sales Revenues:||Drug sales revenues for NITROGLYCERIN|
|What excipients (inactive ingredients) are in NITROGLYCERIN?||NITROGLYCERIN excipients list|
|DailyMed Link:||NITROGLYCERIN at DailyMed|
Recent Clinical Trials for NITROGLYCERIN
Identify potential brand extensions & 505(b)(2) entrants
|Komar University of Science and Technology||Phase 1/Phase 2|
|Aristotle University Of Thessaloniki||Phase 3|
Paragraph IV (Patent) Challenges for NITROGLYCERIN
|NITROLINGUAL PUMPSPRAY||SPRAY, METERED;SUBLINGUAL||nitroglycerin||018705||2012-04-17|
|NITRO-DUR||FILM, EXTENDED RELEASE;TRANSDERMAL||nitroglycerin||020145|
|TRANSDERM-NITRO||FILM, EXTENDED RELEASE;TRANSDERMAL||nitroglycerin||020144|